Compare DTE & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DTE | A |
|---|---|---|
| Founded | 1903 | 1999 |
| Country | United States | United States |
| Employees | 9650 | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4B | 35.8B |
| IPO Year | N/A | 1999 |
| Metric | DTE | A |
|---|---|---|
| Price | $149.35 | $135.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 15 |
| Target Price | $153.31 | ★ $161.47 |
| AVG Volume (30 Days) | 1.1M | ★ 1.6M |
| Earning Date | 04-30-2026 | 05-27-2026 |
| Dividend Yield | ★ 3.17% | 0.92% |
| EPS Growth | N/A | ★ 3.16 |
| EPS | N/A | ★ 2.27 |
| Revenue | N/A | ★ $4,472,000,000.00 |
| Revenue This Year | N/A | $8.45 |
| Revenue Next Year | $3.36 | $6.13 |
| P/E Ratio | ★ $20.29 | $58.75 |
| Revenue Growth | N/A | ★ 6.43 |
| 52 Week Low | $126.23 | $108.35 |
| 52 Week High | $155.75 | $160.27 |
| Indicator | DTE | A |
|---|---|---|
| Relative Strength Index (RSI) | 49.75 | 59.42 |
| Support Level | $140.14 | $122.23 |
| Resistance Level | $150.80 | $140.16 |
| Average True Range (ATR) | 2.45 | 3.74 |
| MACD | -0.47 | -0.04 |
| Stochastic Oscillator | 11.23 | 69.95 |
DTE Energy owns two regulated utilities in Michigan that contribute 90% of earnings. DTE Electric serves approximately 2.3 million customers in southeastern Michigan, including Detroit. DTE Gas serves 1.3 million customers throughout the state. In addition, DTE has nonutility businesses and investments including energy marketing and trading, renewable natural gas facilities, and on-site industrial energy projects.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.